Clincosm LogoSign in Get a demo

Prostate Cancer

Showing NaN - NaN of 197
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Carcinoma Trial in

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Oct 19, 2023

PROSTATE CANCER, Metastatic Prostate Cancer, Metastatic Prostate Carcinoma Trial in Boston (Supervised Circuit Training)

Not yet recruiting
  • PROSTATE CANCER
  • +2 more
  • Supervised Circuit Training
  • Boston, Massachusetts
  • +2 more
Sep 13, 2023

Prostate Cancer Trial in Boston (Ride Share)

Not yet recruiting
  • Prostate Cancer
  • Ride Share
  • Boston, Massachusetts
    Brigham and Women's Hospital
Sep 12, 2023

Prostate Cancer Trial in Boston (Precision screening intervention, Usual care)

Not yet recruiting
  • Prostate Cancer
  • Precision screening intervention
  • Usual care
  • Boston, Massachusetts
    VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain,
Jun 21, 2023

Prostate Cancer, Prostatic Tumors Trial in Boston (High-Intensity Interval Training Exercise Program)

Not yet recruiting
  • Prostate Cancer
  • Prostatic Neoplasms
  • High-Intensity Interval Training Exercise Program
  • Boston, Massachusetts
  • +1 more
Jun 23, 2023

Urologic Cancer, Urologic Tumors, Bladder Cancer Trial in Boston (Electromagnetic Guided Laparoscopy, Ultrasound)

Not yet recruiting
  • Urologic Cancer
  • +7 more
  • Electromagnetic Guided Laparoscopy
  • Ultrasound
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jun 8, 2023

Prostate Disease, Malignancy, Benign Prostatic Hyperplasia Trial in Boston (Self-Administered Nitrous Oxide, Oxygen)

Completed
  • Prostate Disease
  • +6 more
  • Self-Administered Nitrous Oxide
  • Oxygen
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Mar 25, 2023

Prostate Cancer, Prostatic Tumors Trial in Boston, Foxboro (Relugolix, Leuprolide)

Not yet recruiting
  • Prostate Cancer
  • Prostatic Neoplasms
  • Boston, Massachusetts
  • +2 more
Mar 1, 2023

Prostate Cancer, Prostatic Tumors Trial in Boston (PROWESS)

Not yet recruiting
  • Prostate Cancer
  • Prostatic Neoplasms
  • PROWESS
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Feb 22, 2023

Characterization of Prostate Cancer With 3T MR

Active, not recruiting
  • Prostate Cancer
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Jan 26, 2023

    Prostate Cancer Trial in Boston, Detroit, Dallas (Traditional pre-test genetic counseling, Pre-test video education)

    Active, not recruiting
    • Prostate Cancer
    • Traditional pre-test genetic counseling
    • Pre-test video education
    • Boston, Massachusetts
    • +2 more
    Jan 25, 2023

    Prostate Cancer Trial in Worldwide (Enzalutamide, Abiraterone, Placebo for Enzalutamide)

    Completed
    Has Results
    • Prostate Cancer
    • Boston, Massachusetts
    • +91 more
    Jan 18, 2023

    Prostate Cancer Trial in United States (ARN-509 (Phase 1), ARN-509 (Phase 2))

    Active, not recruiting
    Has Results
    • Prostate Cancer
    • ARN-509 (Phase 1)
    • ARN-509 (Phase 2)
    • San Diego, California
    • +14 more
    Jan 17, 2023

    Prostate Cancer, Prostatic Tumor Trial in United States (abiraterone acetate in combination with prednisone)

    Active, not recruiting
    Has Results
    • Prostate Cancer
    • Prostatic Neoplasm
    • abiraterone acetate in combination with prednisone
    • Homewood, Alabama
    • +44 more
    Jan 17, 2023

    Prostate Cancer Trial in Boston (ARN-509, Abiraterone acetate, Prednisone)

    Active, not recruiting
    • Prostate Cancer
    • Boston, Massachusetts
      (unnamed)
    Jan 17, 2023

    Prostate Adenocarcinoma, Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Boston (Apalutamide

    Not yet recruiting
    • Prostate Adenocarcinoma
    • +2 more
    • Apalutamide [Erleada], darolutamide [Nubeqa], or enzalutamide [Xtandi]
    • Prostate-Specific Membrane Antigen (PSMA) PET/CT Scan
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Jan 4, 2023

    Prostate Cancer, Recurrent Adenocarcinoma, Liver Cancer Trial in Boston (MRI Simulator, Radiation Therapy)

    Recruiting
    • Prostate Cancer
    • +3 more
    • MRI Simulator
    • Radiation Therapy
    • Boston, Massachusetts
    • +1 more
    Jan 9, 2023

    Prostate Cancer Trial in United States (bicalutamide, goserelin, mitoxantrone HCl)

    Completed
    Has Results
    • Prostate Cancer
    • Anchorage, Alaska
    • +233 more
    Dec 5, 2022

    Breast Cancer, Prostate Cancer, Patient Engagement Trial in Boston (FOLLOW UP VISIT-TELEMEDICINE, FOLLOW UP VISIT-FACE TO FACE)

    Completed
    • Breast Cancer
    • +4 more
    • FOLLOW UP VISIT-TELEMEDICINE
    • FOLLOW UP VISIT-FACE TO FACE
    • Boston, Massachusetts
    • +1 more
    Dec 19, 2022

    Prostate Cancer Trial in United States (TAK-700, Bicalutamide)

    Active, not recruiting
    Has Results
    • Prostate Cancer
    • Birmingham, Alabama
    • +559 more
    Dec 5, 2022

    Prostate Cancer Trial in Boston, South Weymouth, Londonderry (Nivolumab)

    Recruiting
    • Prostate Cancer
    • Boston, Massachusetts
    • +4 more
    Dec 5, 2022

    Metastatic Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Trial in United States (Darolutamide, Enzalutamide)

    Recruiting
    • Metastatic Prostate Cancer
    • +3 more
    • San Diego, California
    • +11 more
    Nov 28, 2022

    Prostate Cancer Trial in United States (Apalutamide, LHRH Analogue, Abiraterone Acetate)

    Active, not recruiting
    • Prostate Cancer
    • Phoenix, Arizona
    • +68 more
    Nov 28, 2022

    Prostatic Tumors, Castration-Resistant, Tumors by Histologic Type, Tumors, Prostate Trial in United States (P-PSMA-101 CAR-T

    Active, not recruiting
    • Prostatic Neoplasms, Castration-Resistant
    • +16 more
    • Duarte, California
    • +9 more
    Nov 15, 2022

    Metastatic Prostate Cancer, Non-metastatic Prostate Cancer, Prostate Cancer Trial in Boston (Darolutamide, Abemaciclib, GNRH-A

    Not yet recruiting
    • Metastatic Prostate Cancer
    • +2 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Nov 14, 2022